FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents pharmaceutical composition for treating fungal infection nail containing allylamino antifungal compound is present in amount of more than 5 %, C1-C8 carboxylic acid or C1-C4 alkyl ester, diol, selected from propanediol, butanediol, pentanediol, hexanediol or mixtures thereof, and complexing agent of aminoacetic type, and said pharmaceutical composition, in fact, does not contain water.
EFFECT: invention provides increased penetration of active agent in nail, thus increasing efficiency of therapy of fungal infection nail.
19 cl, 5 ex, 5 tbl
Authors
Dates
2016-06-10—Published
2012-02-10—Filed